Aurobindo Pharma inks pact with New Mountain Capital to sell US-based unit for USD 550 mn
​Natrol, which APL acquired in December 2014, has been a consistently profitable business and growing on all fronts under its ownership, claimed APL. The annual sales of Natrol for the 12 months ended March 2020 stood at $156.66 million while the net worth amounted to $82.41million. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 26, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for generic drug
Albuterol is a bronchodilator which helps open up the airways in the lungs to make it easier to breathe. The medicine is used to treat and to prevent bronchospasm. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 23, 2020 Category: Pharmaceuticals Source Type: news

Bharat Biotech in talks to take COVID-19 vaccine candidate global
The potential vaccine was found to be safe without any major adverse events in the first two stages of the trials involving about 1,000 people, Executive Director Sai Prasad said in a phone interview, adding that more than 90% of them developed antibodies against the novel coronavirus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 23, 2020 Category: Pharmaceuticals Source Type: news

Bharat biotech's COVID-19 vaccine Covaxin gets DCGI nod for phase 3 clinical trial
The vaccine 'Covaxin' is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 23, 2020 Category: Pharmaceuticals Source Type: news

WHO says it will have advice on Remdesivir in 3-4 weeks
WHO is preparing its guidelines on the use of the drug Remdesivir to treat COVID-19, and should be able to release it in three to four weeks (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 23, 2020 Category: Pharmaceuticals Source Type: news

USFDA approves use of remdesivir to treat Covid-19 patients in hospitals
The approval of Veklury (remdesivir) was supported by the agency ’s analysis of data from three randomized, controlled clinical trials that included patients hospitalised with mild-to-severe COVID-19, the FDA said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 23, 2020 Category: Pharmaceuticals Source Type: news

Autopsy finds Covid-19 patient ’s lungs ‘hard as a leather ball’
Dr Dinesh Rao of Oxford Medical College, who performed the autopsy, said the lungs of the 62-year-old patient were “hard as a leather ball”, with air sacks ruptured and clots in the blood vessels. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 23, 2020 Category: Pharmaceuticals Source Type: news

IAVI, Merck KGaA, Serum Institute join hands to develop monoclonal antibodies for Covid-19
A phase-I clinical trial is expected to start in early 2021. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 22, 2020 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma arm's New Jersey unit gets warning letter from USFDA
This follows the earlier letter dated June 4, 2020, issuing an OAI (Official Action Indicated) status for this facility. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 22, 2020 Category: Pharmaceuticals Source Type: news

Granules India gets USFDA nod for potassium chloride tablets used to treat hypokalemia
Granules has received marketing approval from the US Food and Drug Administration (USFDA) for Potassium Chloride extended release tablets USP in the strengths of 10 mEq (750 mg) and 20 mEq (1500 mg), the company said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 22, 2020 Category: Pharmaceuticals Source Type: news

Days after Russian COVID-19 vaccine trial approval, data breach forces Dr Reddy's plants shut
In September 2020, Dr. Reddy ’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr. Reddy’s upon regulatory approval in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 22, 2020 Category: Pharmaceuticals Source Type: news

Alembic Pharma JV gets USFDA nod for antifungal topical solution
Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Tavaborole Topical Solution, 5 per cent, Alembic Pharmaceuticals said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 22, 2020 Category: Pharmaceuticals Source Type: news

Purdue Pharma to plead guilty and pay $8.3 billion over opioids
The settlement is likely to boost Purdue's effort to move past claims it helped spark a public-health crisis over opioids with its marketing of OxyContin. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 22, 2020 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets USFDA nod for cholesterol lowering drug
In a regulatory filing, Alembic Pharma said "it has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Fenofibrate capsules USP in the strengths of 67 mg, 134 mg and 200 mg. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 21, 2020 Category: Pharmaceuticals Source Type: news

BDR Pharma launches generic cancer drug in India
BDR Pharmaceuticals on Wednesday said it has launched the generic version of Lenvatinib drug for the treatment of various types of cancers in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 21, 2020 Category: Pharmaceuticals Source Type: news

Strides receives USFDA approval for Ethacrynic Acid Tablets
Strides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte. Ltd, Singapore, has received approval for Ethacrynic Acid Tablets USP, 25 mg from the United States Food& Drug Administration (USFDA). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 20, 2020 Category: Pharmaceuticals Source Type: news

Britain to infect healthy volunteers to speed up COVID-19 vaccine efforts
Britain signed a contract with Open Orphan and its London-based unit, hVivo, that paves the way for human challenge trials, the company said on Tuesday. The plan is to manufacture the virus and conduct a study to determine how much of the pathogen to expose volunteers to in the trials. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 20, 2020 Category: Pharmaceuticals Source Type: news

Remdesivir use may continue in India as few options in sight
Doctors say they find Remdesivir helps reduce viral load in moderate cases. Some, however, question its effectiveness and price. They have also written to the health ministry, suggesting stopping its use, except in clinical trials. “It is an expensive drug and it may be unscientific to continue using it if WHO suggests otherwise,” said a doctor. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 20, 2020 Category: Pharmaceuticals Source Type: news

World Bank says India can use funds for vaccine plans
The World Bank ’s $1-billion support package to help India fight the novel coronavirus can be used for the country’s Covid-19 vaccine programme, an official of the global financial institution said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 20, 2020 Category: Pharmaceuticals Source Type: news

Midwifing the vaccine: The When is visible but there ’s much left to do on the Who and How
The big ‘but’ butts into scalability. The usual sticking point of lab-to-arm is hugely multiplied when dealing with a totally new vaccine against a novel virus to be administered in the midst of a raging pandemic. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 20, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for overactive bladder treatment drug
The company has received final approval from the United States Food and Drug Administration (USFDA) to market Solifenacin Succinate tablets, in the strengths of 5 mg and 10 mg, Zydus Cadila, part of the Cadila Healthcare group, said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 20, 2020 Category: Pharmaceuticals Source Type: news

Vaccine allocation key as supplies will run low for some years: Poonam Khetrapal Singh
"WHO is working on an allocation policy for Covid-19 vaccines and has proposed that the goal of vaccination should be to minimise the societal and economic impact by reducing Covid-19 mortality," said Poonam Khetrapal Singh, regional director, South-East Asia Region, WHO. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 19, 2020 Category: Pharmaceuticals Source Type: news

Glenmark Pharma gets USFDA nod for generic drug
The company's US-based subsidiary has received final approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of PF Prism CV's Rapamune tablets, Glenmark Pharmaceuticals said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 19, 2020 Category: Pharmaceuticals Source Type: news

WHO backs India & South Africa's IPR waiver proposal to WTO for Covid treatment
The move gains significance as global drug makers involved in the development of Covid therapeutics have refused to give up patents over their products. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 19, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets tentative USFDA nod for generic drug
The company has received tentative approval from the US Food and Drug Administration (USFDA) for the product which is the generic version of Pfizer's Xeljanz XR tablets, Zydus Cadila said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 19, 2020 Category: Pharmaceuticals Source Type: news

ABT Group's 'Mirakle' immunity drink being used in 5 Coimbatore hospitals to treat Covid-19 patients
The company now plans to foray into the United States market with Miracle and preliminary talks are on with potential partners, he said. It is also looking to expand the drink ’s foothold in Asean countries after sending its first overseas consignment to Singapore “about a week ago”. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 19, 2020 Category: Pharmaceuticals Source Type: news

US, EU block India's fight for IPR waiver for Covid drugs
At the same time, several developing countries, including China, Pakistan, Thailand, Indonesia and Turkey, have backed the proposal, which is still on the table but needs to be ratified by the WTO Trips Council by the end of the year. It was also supported by the World Health Organisation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 18, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for generic drugs
The company has received final approval from the US Food and Drug Administration (USFDA) for the medication in 300 mg strength, Zydus Cadila said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 17, 2020 Category: Pharmaceuticals Source Type: news

Dr Reddy ’s receives DCGI’s approval to conduct clinical trial for Sputnik V vaccine in India
In September 2020, Dr. Reddy ’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr. Reddy’s upon regulatory approval in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 17, 2020 Category: Pharmaceuticals Source Type: news

Mankind pharma collaborates with Russian RDIF for distribution of Sputnik V in India
Earlier in September, Dr. Reddy ’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 17, 2020 Category: Pharmaceuticals Source Type: news

Panel recommends granting permission to Dr Reddy's for phase 2 trials of Russian COVID vaccine
The Hyderabad-based pharmaceutical firm had on October 13 reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phase 2 and 3 human clinical trials of the vaccine in the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 16, 2020 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets USFDA nod for anti-viral drug
Quoting IQVIA data, Alembic Pharma said Amantadine Hydrochloride Tablets, 100 mg have an estimated market size of USD 13 million for twelve months ending June, 2020. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 16, 2020 Category: Pharmaceuticals Source Type: news

Natco Pharma eyes launch of 8-10 new drugs in India yearly
"Our strategy remains intact as we invest prudently in our research, manufacturing plants and enriching of skill sets. We are on track on our goal to launch 8-10 new products every year across our pharma business segments in India." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 15, 2020 Category: Pharmaceuticals Source Type: news

COVID-19 doubling time improves: Health ministry
In a statement, the Health Ministry said 81,514 new recoveries were added in the last 24 hour. With this, the total number of recoveries is nearly 64 Lakh (63,83,441). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 15, 2020 Category: Pharmaceuticals Source Type: news

International civil groups back India ’s move on TRIPS waiver for Covid cure
​​Leena Menghaney, a lawyer with MSF India, told ET that it is critical for governments to address this global crisis as they did nearly 20 years ago under the Doha Declaration on the TRIPS Agreement and Public Health amidst the HIV/AIDS epidemic. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 14, 2020 Category: Pharmaceuticals Source Type: news

ICMR approaches experts panel to approve testing of cancer drug acalabrutinib for Covid treatment
ICMR ’s National AIDS Research Institute (NARI) had presented a proposal to the Subject Expert Committee (SEC) formed to review Covid related proposals seeking to amend Solidarity’s ongoing protocol by adding a trial arm to test acalabrutinib. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 14, 2020 Category: Pharmaceuticals Source Type: news

Covid fatality rate 1.2% without co-morbidities, 18% with them: Government data
The latest age-wise analysis of Covid-19 mortality by the health ministry showed that those in the younger age band were more vulnerable to the disease, though the fatality rate continues to be higher at 53 per cent among people over 60 years of age. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 14, 2020 Category: Pharmaceuticals Source Type: news

Remdesivir allowed in moderate cases
Currently, remdesivir is allowed for emergency/compassionate use in treating severely-ill Covid-19 patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 13, 2020 Category: Pharmaceuticals Source Type: news

Six Indian drug companies to set up a large pharma cluster in Mexico
A commerce ministry official said a couple of Indian drug makers have also agreed, in principle, to set up manufacturing facilities in Hidalgo to make Mexico their production and logistics hub and cater to Latin American regions. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 13, 2020 Category: Pharmaceuticals Source Type: news

Alembic Pharma arm inks pact with Curon to develop cancer treatment drug in Greater China
As per the agreement, Rhizen will receive an undisclosed upfront cash payment and is eligible to receive additional development and commercial milestone payments with an overall deal value of USD 149.5 million plus double-digit royalties. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 13, 2020 Category: Pharmaceuticals Source Type: news

India generated over 18,000 tonnes COVID-19 waste since June; Maharashtra biggest contributor
According to the data received from state pollution control boards, since June, all states and Union Territories have generated 18,006 tonnes of COVID-19-related biomedical waste. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 12, 2020 Category: Pharmaceuticals Source Type: news

Sun Pharma recalls 747 bottles of generic diabetes drug from the American market
As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Sun Pharmaceutical Industries is recalling the bottles of RIOMET ER (metformin hydrochloride for extended-release oral suspension) in the American market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 11, 2020 Category: Pharmaceuticals Source Type: news

UK study tests if BCG tuberculosis vaccine protects against coronavirus
Bacillus Calmette-Guerin (BCG) vaccine, used to protect against tuberculosis, induces a broad innate immune-system response and has been shown to protect against infection or severe illness with other respiratory pathogens. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 11, 2020 Category: Pharmaceuticals Source Type: news

Inhaled vaccines aim to fight Coronavirus at its point of attack
Most vaccines in human testing require two shots for effectiveness, and developers still aren ’t even sure if they’ll prevent infections. Scientists are hoping to generate superior immune responses with inhaled vaccines that directly target the airway cells the virus invades. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 11, 2020 Category: Pharmaceuticals Source Type: news

Bharat Biotech asked to submit complete phase 2 data of its COVID-19 vaccine before phase 3 trial
According to officials, the Hyderabad-based vaccine maker applied to the Drugs Controller General of India (DCGI) on October 2, seeking its permission to conduct phase-3 randomised double-blind placebo-controlled multicentre trial of its COVID-19 vaccine candidate. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 10, 2020 Category: Pharmaceuticals Source Type: news

No 'significant' benefit of favipiravir, umifenovir combination in Covid treatment: Glenmark
Glenmark had in May intimated the study to examine whether early administration of a combination of Favipiravir and Umifenovir enhances antiviral efficacy on Covid-19 patients. The company said that addition of Umifenovir did not demonstrate any additional benefit over Favipiravir alone in moderate Covid-19 patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 9, 2020 Category: Pharmaceuticals Source Type: news

India declines proposal to test Sputnik-V Covid vaccine in large study
India's move comes as a setback for Russia's plan to roll-out the vaccine even before full trials show how well it works, while pushing back its efforts to win approval for the vaccine in the country that leads the world on average number of new infections. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 8, 2020 Category: Pharmaceuticals Source Type: news

After tablets, Hetero working on antiviral medicine Favipiravir injections
If successful, Hetero will become the first Indian drug maker to introduce favipiravir in injection form which is hitherto available only in oral form, and emerge as one of the few global firms to record such a feat. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 8, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila launches new product for COPD patients in India
Drug firm Zydus Cadila on Thursday said it is launching pressurized metered dose inhaler for patients suffering from Chronic Obstructive Pulmonary Disease (COPD) in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 8, 2020 Category: Pharmaceuticals Source Type: news

Centre to map out cold chain storage facilities in preparation for COVID-19 vaccine delivery
A national expert group is talking to public and private sector entities in the pharmaceutical sector, food processing industry and agro businesses as well as food delivery start-ups such as Swiggy and Zomato to identify cold storages or fridges at the taluka level that can stock and distribute the vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 8, 2020 Category: Pharmaceuticals Source Type: news